Clinical Trial Update: Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study evaluating decitabine maintenance after bone marrow transplant in higher-risk myelodysplastic syndrome and MDS/AML.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 | Status: UNKNOWN